why choose us

First received: December 21, 2022

Clinical Trial: A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Graft-versus-host Disease

Study Type: INTERVENTIONAL


Official Title: A Phase Ib, Open-label, Randomized, Dose-finding, Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of GDC-8264 in Combination With Standard of Care in the Treatment of Acute Gr

Brief Summary: The primary purpose of the study is to assess the safety and pharmacokinetics (PK) of GDC-8264 in participants with acute graft-versus-host disease (aGVHD).

Read more